The Jackson Laboratory (JAX) Center for Precision Genetics (JCPG) will leverage JAX's eight decades of expertise in mammalian genetics and disease modeling to develop and disseminate new, precise animal models of incurable and genetically complex human diseases. The JCPG will bring together an international, multi-disciplinary team?including geneticists and genetics technology experts, quantitative and computational biologists, clinical experts in specific disease areas and world leaders in the development of precision animal models of disease?that possesses the collective ability to foresee disease modeling needs as they emerge on the international stage. This will allow the JCPG to serve investigators in a variety of disease areas on a regional, national and international basis. Six projects will address intractable or incurable diseases linked by genetic complexity, molecular genetic data and/or ?humanization? that represent diverse stages of preclinical development. The JCPG will generate new disease modeling processes and pipelines, data resources, research results and models that will be swiftly shared through JAX's proven dissemination pipelines with other Precision Disease Modeling Centers, academic medical centers and research institutions worldwide. Ultimately, this will accelerate the application of advances in basic science for the greatest possible medical benefit. The Coordination (Admin) Core oversees all administrative and scientific functions of the JCPG. Under the direction of this application PI, Wayne Frankel, Ph.D., and the JCPG Project Manager (to be hired), the Core will execute its duties with oversight from an External Advisory Board (EAB) and a Center Steering Committee (CSC), both of which will convene biannually; other organized administrative and scientific meetings will be held weekly and monthly. All meetings and oversight will be focused on ensuring that the JCPG achieves its mission, aims, milestones and metrics. Toward this end, the Coordination Core will catalyze synergy between and among JCPG projects, and will foster close interaction with the Genetics Engineering Technologies (GET) service, and Bioinformatics and Preclinical/Co-clinical Cores, thus facilitating the speed of discovery while reducing overall cost. The Coordination Core will also optimize positive ?peer pressure? on each project team by fostering comparisons between projects that are using the same approach or technique to address different disease areas. Thus, the Coordination Core will ensure that discoveries made in one area of the JCPG will benefit the whole, leading to efficiencies in time and cost that would not be possible with isolated, individual projects.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54OD020351-05
Application #
9726111
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Presa, Maximiliano; Racine, Jeremy J; Dwyer, Jennifer R et al. (2018) A Hypermorphic Nfkbid Allele Contributes to Impaired Thymic Deletion of Autoreactive Diabetogenic CD8+ T Cells in NOD Mice. J Immunol 201:1907-1917
Schloss, Jennifer; Ali, Riyasat; Racine, Jeremy J et al. (2018) HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression. J Immunol 200:3353-3363
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Korstanje, Ron; Ryan, Jennifer L; Savage, Holly S et al. (2017) Continuous Glucose Monitoring in Female NOD Mice Reveals Daily Rhythms and a Negative Correlation With Body Temperature. Endocrinology 158:2707-2712
Snyder, Elizabeth M; McCarty, Christopher; Mehalow, Adrienne et al. (2017) APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo. RNA 23:457-465
Wang, Qiming; Racine, Jeremy J; Ratiu, Jeremy J et al. (2017) Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy. J Immunol 199:3757-3770
Rodvold, Jeffrey J; Chiu, Kevin T; Hiramatsu, Nobuhiko et al. (2017) Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells. Sci Signal 10:
Liu, Edison T; Bolcun-Filas, Ewelina; Grass, David S et al. (2017) Of mice and CRISPR: The post-CRISPR future of the mouse as a model system for the human condition. EMBO Rep 18:187-193
Ratiu, Jeremy J; Racine, Jeremy J; Hasham, Muneer G et al. (2017) Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes. J Immunol 198:4255-4267
Morelli, Kathryn H; Seburn, Kevin L; Schroeder, David G et al. (2017) Severity of Demyelinating and Axonal Neuropathy Mouse Models Is Modified by Genes Affecting Structure and Function of Peripheral Nodes. Cell Rep 18:3178-3191

Showing the most recent 10 out of 13 publications